Jan 15, 2020 / 04:30PM GMT
Eric William Joseph - JP Morgan Chase & Co, Research Division - VP & Senior Analyst
All right, great. We'll get started here. I'm Eric Joseph, senior biotech analyst at JPMorgan. And our next presenting company is PTC Therapeutics. It's my pleasure to introduce Stuart Peltz to tell us a little bit about the company. Before we begin, I just want to remind the audience that the breakout session, the breakout Q&A is going to be across the hall in the Georgian room. With that, Stu?
Stuart W. Peltz - PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director
Okay. Well, thank you all, both here and on the web, for coming today. And what I want to do is just tell you about PTC. We will be making some forward-looking statements, so I'll refer you to our SEC filings. So I thought I'd start to say, who are we? We're a global commercial diversified biopharmaceutical company that's focused on innovative therapies for rare genetic disorders.
And I thought what I'd do today is to dissect that for you a bit, break it down. So you understand the
PTC Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers